Geneva, Dec. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12625001377426) titled 'Feasibility, safety, and usability assessment of the Wellumio Axana portable magnetic resonance device for diagnosis of stroke' on Dec. 9.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Non-randomised trial
Primary Sponsor: Wellumio, Ltd
Condition:
Stroke
Stroke
Stroke - Ischaemic
Stroke - Haemorrhagic
Intervention:
Use of a portable (100kg) ultra-low-field (0.1 Tesla) magnetic resonance device for the diagnosis of stroke and differentiation of stroke type
- The 'Axana' device is a portable ~100kg ultra-low-field magnetic resonance device that utilises a fixed magnet Aubert ring...